New Releases from NCBI BookshelfDurvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer.​Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer.